CEMI - Chembio Diagnostics, Inc. Stock Price and Quote

CEMI [NASD]

Healthcare | Diagnostics & Research | USA

Index	-	P/E	-	EPS (ttm)	-1.19	Insider Own	1.08%	Shs Outstand	36.71M	Perf Week	-18.81%
Market Cap	12.10M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	36.31M	Perf Month	-21.10%
Income	-36.40M	PEG	-	EPS next Q	-	Inst Own	8.80%	Short Float / Ratio	2.41% / 1.37	Perf Quarter	15.89%
Sales	59.80M	P/S	0.20	EPS this Y	-4.30%	Inst Trans	22.91%	Short Interest	0.88M	Perf Half Y	-22.22%
Book/sh	0.55	P/B	0.64	EPS next Y	-	ROA	-57.30%	Target Price	-	Perf Year	-55.62%
Cash/sh	0.61	P/C	0.57	EPS next 5Y	25.00%	ROE	-147.90%	52W Range	0.19 - 1.24	Perf YTD	59.31%
Dividend	-	P/FCF	-	EPS past 5Y	-2.10%	ROI	-58.10%	52W High	-71.77%	Beta	1.88
Dividend %	-	Quick Ratio	1.00	Sales past 5Y	21.80%	Gross Margin	13.00%	52W Low	84.21%	ATR	0.02
Employees	337	Current Ratio	1.20	Sales Q/Q	-7.40%	Oper. Margin	-56.00%	RSI (14)	30.58	Volatility	12.83% 4.24%
Optionable	Yes	Debt/Eq	1.08	EPS Q/Q	12.90%	Profit Margin	-60.90%	Rel Volume	1.40	Prev Close	0.35
Shortable	Yes	LT Debt/Eq	0.01	Earnings	-	Payout	-	Avg Volume	637.85K	Price	0.35
Recom	3.00	SMA20	-18.83%	SMA50	-11.92%	SMA200	-27.96%	Volume	893,266	Change	0.00%

Jul-22-21

Downgrade

Colliers Securities

Buy → Neutral

Dec-03-20

Upgrade

Craig Hallum

Hold → Buy

$5 → $10

Nov-06-20

Upgrade

Colliers Securities

Neutral → Buy

$7.50

Jun-17-20

Downgrade

The Benchmark Company

Speculative Buy → Hold

Jun-17-20

Downgrade

Craig Hallum

Buy → Hold

Jun-17-20

Downgrade

Canaccord Genuity

Buy → Hold

May-26-20

Initiated

Robert W. Baird

Outperform

$21

Mar-04-20

Reiterated

The Benchmark Company

Speculative Buy

$9 → $6

Mar-04-20

Reiterated

The Benchmark Company

Speculative Buy

$9 → $5

Dec-19-18

Initiated

Dougherty & Company

Buy

Show Previous Ratings

Mar-15-23 07:00AM	Chembio Announces Letter to Stockholders Regarding Tender Offer GlobeNewswire -12.13%
07:00AM	Biosynex Extends Tender Offer for the shares of Chembio Diagnostics, Inc. GlobeNewswire
Feb-24-23 08:00AM	Chembio Announces the Receipt of CLIA Waiver for its DPP HIV-Syphilis System GlobeNewswire
Feb-01-23 11:01AM	French Rapid Testing Company Scoops Up Chembio Diagnostics For $17M Benzinga +23.33%
Jan-31-23 05:00PM	Biosynex and Chembio Diagnostics Announce Definitive Acquisition Agreement GlobeNewswire
08:00AM	Loading…
Nov-28-22 08:00AM	Chembio Announces FDA CLIA Waiver Submission for DPP HIV-Syphilis System GlobeNewswire
Nov-03-22 04:05PM	Chembio Diagnostics Reports Third Quarter 2022 Financial Results GlobeNewswire -7.11%
Oct-20-22 04:05PM	Chembio Diagnostics to Report Third Quarter 2022 Financial Results on November 3, 2022 GlobeNewswire
Sep-06-22 08:00AM	Chembio Diagnostics Awarded $3.2 Million Contract from the CDC for Development and Clinical Validation of Dual-Path Platform Syphilis Screen & Confirm Assay GlobeNewswire -7.69%
Aug-26-22 01:15PM	Is Monkeypox Outbreak Cooling? Health Officials Says Virus Transmission Has Slowed Benzinga -5.46%
Aug-16-22 11:50AM	Rapid Test For Monkeypox? NY-Based Chembio Diagnostics Thinks They Can Pull It Off Benzinga
08:00AM	Chembio Diagnostics Evaluates Monkeypox Rapid Point-of-Care Test Development GlobeNewswire
Aug-04-22 04:05PM	Chembio Diagnostics Reports Second Quarter 2022 Financial Results GlobeNewswire
Jul-21-22 04:05PM	Chembio Diagnostics to Report Second Quarter 2022 Financial Results on August 4, 2022 GlobeNewswire
Jun-15-22 08:00AM	Chembio Diagnostics Announces Expansion of Direct-to-Consumer Commercial Channel GlobeNewswire
04:15PM	Loading…
May-24-22 04:15PM	Chembio Diagnostics Announces Election of Leslie Teso-Lichtman to Its Board of Directors GlobeNewswire
May-17-22 08:00AM	Chembio Diagnostics Announces Agreement for Reszon Diagnostics International to Manufacture Chembios HIV 1/2 STAT-PAK Assay at Chembio Diagnostics Malaysia Facility GlobeNewswire +13.68%
May-05-22 04:05PM	Chembio Diagnostics Reports First Quarter 2022 Financial Results GlobeNewswire +8.78%
Apr-21-22 04:05PM	Chembio Diagnostics to Report First Quarter 2022 Financial Results on May 5, 2022 GlobeNewswire
Mar-03-22 04:05PM	Chembio Diagnostics Reports Fourth Quarter and Full Year 2021 Financial Results GlobeNewswire
Feb-17-22 04:05PM	Chembio Diagnostics to Report Fourth Quarter and Full Year 2021 Financial Results on March 3, 2022 GlobeNewswire -5.66%
Jan-10-22 05:38PM	Penbrook Management LLC Buys Cohu Inc, Kulicke & Soffa Industries Inc, PubMatic Inc, Sells ... GuruFocus.com +8.33%
Jan-06-22 04:05PM	Chembio Diagnostics Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
07:29AM	Todays Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday InvestorPlace
Jan-05-22 04:05PM	Chembio Diagnostics Announces Appointment of Larry Steenvoorden as Chief Financial Officer GlobeNewswire
Dec-29-21 06:46AM	Chembio Diagnostics Slides After FDA Declines to Review EUA Investing.com -30.13%
Dec-17-21 04:49PM	Penny Stocks to Watch for January 2022 Investopedia +6.17%
Dec-06-21 08:00AM	Chembio Diagnostics Submits FDA De Novo/510(k) Request for DPP SARS-CoV-2 Antigen Test System GlobeNewswire
Nov-29-21 08:00AM	Chembio Diagnostics Receives SAHPRA Approval for DPP SARS-CoV-2 Antigen Test GlobeNewswire +6.50%
Nov-22-21 08:00AM	Chembio Diagnostic Systems Prevails in International Arbitration Against BioSure (UK) Ltd GlobeNewswire
08:19AM	Loading…
Nov-17-21 08:19AM	Chembio Files For FDA Emergency Use Nod For COVID-19 Antigen Test Benzinga
Nov-16-21 04:05PM	Chembio Diagnostics Submits EUA Application for New DPP SARS-CoV-2 Antigen Test GlobeNewswire
Nov-15-21 08:00AM	Chembio Diagnostics Announces Extension of Delivery Schedule for Bio Manguinhos Purchase Order of DPP SARS-COV-2 Antigen Tests GlobeNewswire
Nov-09-21 05:12AM	Shareholders in Chembio Diagnostics (NASDAQ:CEMI) are in the red if they invested five years ago Simply Wall St.
Nov-04-21 04:05PM	Chembio Diagnostics Reports Third Quarter 2021 Financial Results GlobeNewswire
Oct-21-21 04:51PM	Chembio Diagnostics to Report Third Quarter 2021 Financial Results on November 4, 2021 GlobeNewswire
Sep-22-21 08:00AM	Chembio Announces EUA Submission for DPP Respiratory Antigen Panel GlobeNewswire
Sep-10-21 07:02AM	20 Stocks Moving in Friday's Pre-Market Session Benzinga
Aug-30-21 09:38AM	Company News for Aug 30, 2021 Zacks -6.02%
Aug-27-21 03:43PM	Why Chembio Diagnostics Shares Are Trading Higher Today Benzinga +11.15%
08:00AM	Chembio Launches Commercial Distribution of Third-Party COVID-19 Antigen Assay GlobeNewswire
06:30AM	Chembio Stock Climbs on Commercial Distribution Launch of COVID Test TheStreet.com
Aug-08-21 03:15AM	Analysts' Revenue Estimates For Chembio Diagnostics, Inc. (NASDAQ:CEMI) Are Surging Higher Simply Wall St.
Aug-06-21 10:46AM	Implied Volatility Surging for Chembio Diagnostics (CEMI) Stock Options Zacks -14.49%
Aug-05-21 04:05PM	Chembio Diagnostics Reports Second Quarter 2021 Financial Results GlobeNewswire
Jul-22-21 05:03PM	Chembio Diagnostics to Report Second Quarter 2021 Financial Results on August 5, 2021 GlobeNewswire -19.29%
12:49PM	Chembio Diagnostics Receives $4 Million HIV Test Purchase Order Supported by The Global Fund GlobeNewswire
01:04AM	Tesla and Bitcoin, Activision, AT&T, Chembio - 5 Things You Must Know Thursday TheStreet.com
Jul-21-21 01:28PM	Why Is Chembio Diagnostics (NASDAQ: CEMI) The Best Stock Of The Day? Benzinga +159.22%
08:50AM	Chembio's stock more than doubles off 11-year low after large order for COVID-19 antigen tests MarketWatch
04:49AM	Chembio Shares Double on $28 Million COVID Diagnostic Test Order TheStreet.com
04:35AM	Premarket Movers Wednesday: Chembio, NeuroMetrix, Johnson & Johnson TheStreet.com
May-06-21 04:05PM	Chembio Diagnostics Reports First Quarter 2021 Financial Results GlobeNewswire
02:30PM	Chembio Diagnostics, Inc. to Host Earnings Call ACCESSWIRE
Apr-22-21 08:00AM	Chembio Diagnostics to Report First Quarter 2021 Financial Results on May 6, 2021 GlobeNewswire
Apr-07-21 02:51AM	If You Had Bought Chembio Diagnostics' (NASDAQ:CEMI) Shares Three Years Ago You Would Be Down 39% Simply Wall St. -10.37%
Apr-05-21 01:35PM	Chembio Diagnostics stock rockets on record volume after commercial launch of rapid COVID-19 test MarketWatch +60.23%
11:43AM	Chembio Jumps on Launch of Test Distinguishing COVID, Flu TheStreet.com
Apr-01-21 05:30PM	Chembio Announces U.S. Commercial Launch of Diagnostic Tool to Differentiate COVID-19 and Flu GlobeNewswire
Mar-11-21 04:05PM	Chembio Diagnostics Reports Fourth Quarter and Full Year 2020 Financial Results GlobeNewswire +5.11%
02:30PM	Chembio Diagnostics, Inc. to Host Earnings Call ACCESSWIRE
Mar-10-21 10:13AM	Chembio Diagnostics's Earnings Outlook Benzinga
Mar-08-21 08:00AM	Chembio Diagnostics Appoints Industry Leader David Bespalko to its Board of Directors GlobeNewswire +11.21%
Feb-25-21 04:05PM	Chembio Diagnostics to Report Fourth Quarter and Full Year 2020 Financial Results on March 11, 2021 GlobeNewswire
Feb-03-21 12:23AM	Do Insiders Own Lots Of Shares In Chembio Diagnostics, Inc. (NASDAQ:CEMI)? Simply Wall St.
Jan-14-21 07:00AM	Chembio Diagnostics Announces CE Mark for DPP SARS-CoV-2 Antigen and IgM/IgG Test Systems GlobeNewswire +9.28%
Dec-17-20 04:05PM	Chembio Diagnostics Appoints David Acheson, M.D. to its Board of Directors GlobeNewswire +7.71%
Dec-05-20 02:15AM	Is Chembio Diagnostics (NASDAQ:CEMI) Using Too Much Debt? Simply Wall St.
Dec-04-20 08:49AM	Are Options Traders Betting on a Big Move in Chembio Diagnostics (CEMI) Stock? Zacks -13.98%
Dec-03-20 08:48AM	Chembio Diagnostics (CEMI) Surges: Stock Moves 8.5% Higher Zacks +6.68%
Dec-02-20 01:22PM	Chembio Diagnostics Awarded $12.7 Million by BARDA for Development of Rapid DPP Respiratory Antigen Panel and 510(k) Submission of the Rapid DPP SARS-CoV-2 Antigen Test System GlobeNewswire +8.47%
Nov-27-20 01:10PM	Is Chembio Diagnostics Inc (CEMI) A Good Stock To Buy? Insider Monkey
Nov-13-20 04:40PM	Chembio Diagnostics Receives ANVISA Approval for DPP SARS-CoV-2 Antigen Test System in Brazil GlobeNewswire
Nov-05-20 04:05PM	Chembio Diagnostics Reports Third Quarter 2020 Financial Results GlobeNewswire
02:30PM	Chembio Diagnostics, Inc. to Host Earnings Call ACCESSWIRE
Oct-23-20 08:00AM	Chembio Diagnostics to Report Third Quarter 2020 Financial Results on November 5, 2020 GlobeNewswire
Oct-16-20 07:15AM	The Daily Biotech Pulse: Amarin Vascepa Data, Galapagos Osteoarthritis Drug Update, 4 IPOs Benzinga
Oct-15-20 05:55PM	Chembio Diagnostics Submits EUA Application for DPP SARS-CoV-2 Antigen Test System GlobeNewswire
Oct-06-20 08:38AM	Introducing Chembio Diagnostics (NASDAQ:CEMI), A Stock That Climbed 18% In The Last Five Years Simply Wall St. -9.56%
Oct-02-20 10:10AM	Return On Capital Employed Overview: Chembio Diagnostics Benzinga
07:26AM	Chembio Diagnostics Receives FDA Approval for DPP HIV-Syphilis System GlobeNewswire
Sep-25-20 08:55AM	Implied Volatility Surging for Chembio (CEMI) Stock Options Zacks +12.11%
Sep-08-20 06:00PM	Chembio Submits EUA Application for New DPP SARS-CoV-2 IgM/IgG Test System GlobeNewswire +8.26%
Aug-25-20 08:57AM	Are Options Traders Betting on a Big Move in Chembio Diagnostics (CEMI) Stock? Zacks
Aug-17-20 02:15PM	CLASS ACTION UPDATE for ENPH, CEMI and BKD: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
11:50AM	DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Chembio Diagnostics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
11:40AM	SHAREHOLDER ALERT: ENPH CEMI CODX: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
11:01AM	CEMI FINAL DEADLINE: Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action Against Chembio Diagnostics, Inc. and Lead Plaintiff Deadline: August 17, 2020 ACCESSWIRE
07:30AM	SHAREHOLDER ALERT: PRA ENPH CEMI: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
06:55AM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Chembio Diagnostics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 17, 2020 - CEMI Newsfile
Aug-16-20 03:09PM	CEMI DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action Against Chembio Diagnostics, Inc. and Lead Plaintiff Deadline: August 17, 2020 ACCESSWIRE
11:44AM	DEADLINE MONDAY ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Chembio Diagnostics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
10:51AM	CLASS ACTION UPDATE for CEMI, KL and JCOM: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
Aug-15-20 02:35PM	FINAL DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Chembio Diagnostics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
Aug-14-20 03:55PM	SHAREHOLDER ALERT: CEMI CODX KL: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
02:25PM	IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Chembio Diagnostics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
01:00PM	CEMI DEADLINE: Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action Against Chembio Diagnostics, Inc. and Lead Plaintiff Deadline: August 17, 2020 Newsfile
12:00PM	The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Chembio Diagnostics, Inc. (CEMI) Business Wire
10:00AM	CEMI ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of August 17, 2020 in the Class Action Filed on Behalf of Chembio Diagnostics, Inc. Limited Shareholders Newsfile
09:31AM	MONDAY DEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Chembio Diagnostics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile

Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, lassa, marburg, leptospirosis, rickettsia, and Burkholderia diseases. The company sells its products under the STAT-PAK, SURE CHECK, STAT VIEW, and DPP trademarks, as well as sells its products directly through distributors to medical laboratories and hospitals, governmental and public health entities, non-governmental organizations, medical professionals, and retail establishments in the United States and internationally. It has collaboration agreements with Bill & Melinda Gates Foundation, The Paul G. Allen Family Foundation, The Oswaldo Cruz Foundation, and the Foundation for Innovative New Diagnostics, as well as U.S. government agencies, such as Centers for Disease Control and Prevention, the Biomedical Advanced Research and Development Authority of the U.S. Department of Health and Human Services, and the U.S. Department of Agriculture. Chembio Diagnostics, Inc. was founded in 1985 and is headquartered in Hauppauge, New York.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Upgrade your FINVIZ experience